How many institutional investors hold ZVRA?

3 tracked institutional investors disclosed a position in ZVRA (ZEVRA THERAPEUTICS INC) in their most recent 13F filing.

Who is the largest institutional holder of ZVRA?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ZVRA, valued at $11M.

Did institutional ownership of ZVRA increase or decrease?

Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited ZVRA.

Where does this ZVRA ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ZVRA — ZEVRA THERAPEUTICS INC

Name: ZEVRA THERAPEUTICS INC (ZVRA) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ZVRA?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net distribution · 0 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

No tracked investor changed their ZVRA position last quarter. Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence

+3 tracked investors reported holding ZVRA at their latest filing
+Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About ZEVRA THERAPEUTICS INC (ZVRA)

ZEVRA THERAPEUTICS INC (ZVRA) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $11M. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ZVRA

/100

Mixed Activity

Added / Increased0

Reduced0

Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track ZVRA

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

ZVRA Ownership Composition

How ZEVRA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

51% of tracked value

Institutions

tracked investors

Total Reported

$14.7M

combined 13F value

Multi-Strategy / Quant50.5%
Macro49.5%

Multi-Strategy / Quant(2)

50.5%

Macro(1)

49.5%

Tracked investors currently reporting ZVRA

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	90.5K	$1.3M	0.00%	Jun 30, 2026
Ken Griffin	Citadel Advisors	426.4K	$6.1M	0.00%	Jun 30, 2026
Paul Tudor Jones	Tudor Investment Corp	505.9K	$7.3M	0.01%	Jun 30, 2026

Izzy EnglanderJun 30, 2026
Millennium Management
Shares
90.5K
Value
$1.3M
% Portfolio
0.00%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
426.4K
Value
$6.1M
% Portfolio
0.00%
Paul Tudor JonesJun 30, 2026
Tudor Investment Corp
Shares
505.9K
Value
$7.3M
% Portfolio
0.01%

Previously held ZVRA

These investors reported ZVRA in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Steve Cohen	Point72 Asset Management	1.2M	$10.8M	Mar 31, 2026

Recent activity

Investor	Action	Δ %	Current value	Filing date
No recent activity.

No recent activity.

Frequently asked questions

How many institutional investors hold ZVRA?: 3 tracked institutional investors disclosed a position in ZVRA (ZEVRA THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of ZVRA?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ZVRA, valued at $11M.
Did institutional ownership of ZVRA increase or decrease?: Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited ZVRA.
Where does this ZVRA ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.